This is an addendum to the ‘Guideline on clinical investigation of medicinal products in the treatment of acute heart failure’ (CHMP/EWP/2986/03 Rev. 1). It is not meant as a guidance document on its own but rather highlights differences from adult patients with Acute Heart Failure (AHF) and points out paediatric-specific aspects.

 

 

Posted on the EMA website on 10 June 2015